Trust Company of Vermont’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $132K | Buy |
+1,534
| New | +$135K | ﹤0.01% | 431 |
|
|
2025
Q4 | $160K | Buy |
1,780
+6
| +0.3% | +$569 | 0.01% | 385 |
|
|
2025
Q3 | $175K | Buy |
1,774
+40
| +2% | +$3.96K | 0.01% | 373 |
|
|
2025
Q2 | $158K | Sell |
1,734
-50
| -3% | -$4.83K | 0.01% | 377 |
|
|
2025
Q1 | $202K | Sell |
1,784
-402
| -18% | -$43K | 0.01% | 342 |
|
|
2024
Q4 | $231K | Sell |
2,186
-301
| -12% | -$32.3K | 0.01% | 327 |
|
|
2024
Q3 | $268K | Buy |
2,487
+566
| +29% | +$61.8K | 0.01% | 299 |
|
|
2024
Q2 | $208K | Buy |
1,921
+9
| +0.5% | +$1.06K | 0.01% | 313 |
|
|
2024
Q1 | $252K | Buy |
1,912
+582
| +44% | +$72.7K | 0.01% | 287 |
|
|
2023
Q4 | $162K | Sell |
1,330
-622
| -32% | -$69.4K | 0.01% | 306 |
|
|
2023
Q3 | $219K | Sell |
1,952
-95
| -5% | -$12.1K | 0.01% | 288 |
|
|
2023
Q2 | $298K | Hold |
2,047
| – | – | 0.02% | 271 |
|
|
2023
Q1 | $264K | Sell |
2,047
-17
| -0.8% | -$2.13K | 0.02% | 284 |
|
|
2022
Q4 | $263K | Sell |
2,064
-137
| -6% | -$15.9K | 0.02% | 270 |
|
|
2022
Q3 | $230K | Buy |
2,201
+15
| +0.7% | +$1.65K | 0.02% | 279 |
|
|
2022
Q2 | $230K | Sell |
2,186
-351
| -14% | -$41.6K | 0.02% | 285 |
|
|
2022
Q1 | $325K | Sell |
2,537
-102
| -4% | -$12.3K | 0.02% | 258 |
|
|
2021
Q4 | $325K | Sell |
2,639
-495
| -16% | -$64.8K | 0.02% | 272 |
|
|
2021
Q3 | $446K | Sell |
3,134
-259
| -8% | -$38.1K | 0.03% | 227 |
|
|
2021
Q2 | $530K | Sell |
3,393
-36
| -1% | -$5.83K | 0.04% | 220 |
|
|
2021
Q1 | $533K | Sell |
3,429
-61
| -2% | -$9.45K | 0.04% | 215 |
|
|
2020
Q4 | $522K | Sell |
3,490
-56
| -2% | -$7.91K | 0.04% | 204 |
|
|
2020
Q3 | $468K | Sell |
3,546
-300
| -8% | -$39.2K | 0.04% | 199 |
|
|
2020
Q2 | $446K | Sell |
3,846
-84
| -2% | -$9.68K | 0.04% | 200 |
|
|
2020
Q1 | $385K | Sell |
3,930
-274
| -7% | -$35.9K | 0.04% | 220 |
|
|
2019
Q4 | $611K | Buy |
4,204
+25
| +0.6% | +$3.45K | 0.05% | 204 |
|
|
2019
Q3 | $557K | Sell |
4,179
-23
| -0.5% | -$2.97K | 0.04% | 214 |
|
|
2019
Q2 | $481K | Buy |
4,202
+342
| +9% | +$40.1K | 0.04% | 220 |
|
|
2019
Q1 | $479K | Sell |
3,860
-36
| -0.9% | -$4.09K | 0.04% | 223 |
|
|
2018
Q4 | $392K | Sell |
3,896
-146
| -4% | -$16.4K | 0.04% | 231 |
|
|
2018
Q3 | $516K | Buy |
4,042
+27
| +0.7% | +$3.21K | 0.04% | 222 |
|
|
2018
Q2 | $435K | Buy |
4,015
+78
| +2% | +$8.49K | 0.04% | 232 |
|
|
2018
Q1 | $417K | Sell |
3,937
-154
| -4% | -$17.9K | 0.04% | 231 |
|
|
2017
Q4 | $479K | Sell |
4,091
-142
| -3% | -$16.1K | 0.04% | 227 |
|
|
2017
Q3 | $481K | Hold |
4,233
| – | – | 0.05% | 223 |
|
|
2017
Q2 | $528K | Buy |
4,233
+154
| +4% | +$18.3K | 0.05% | 219 |
|
|
2017
Q1 | $484K | Sell |
4,079
-36
| -0.9% | -$4.08K | 0.05% | 217 |
|
|
2016
Q4 | $412K | Sell |
4,115
-265
| -6% | -$28.4K | 0.05% | 222 |
|
|
2016
Q3 | $553K | Buy |
4,380
+258
| +6% | +$31.9K | 0.07% | 183 |
|
|
2016
Q2 | $482K | Buy |
4,122
+58
| +1% | +$6.56K | 0.06% | 186 |
|
|
2016
Q1 | $421K | Hold |
4,064
| – | – | 0.06% | 186 |
|
|
2015
Q4 | $405K | Hold |
4,064
| – | – | 0.06% | 190 |
|
|
2015
Q3 | $371K | Sell |
4,064
-11
| -0.3% | -$1.1K | 0.06% | 191 |
|
|
2015
Q2 | $432K | Buy |
4,075
+44
| +1% | +$4.87K | 0.06% | 183 |
|
|
2015
Q1 | $460K | Sell |
4,031
-78
| -2% | -$8.9K | 0.07% | 178 |
|
|
2014
Q4 | $452K | Sell |
4,109
-32
| -0.8% | -$3.37K | 0.07% | 182 |
|
|
2014
Q3 | $404K | Hold |
4,141
| – | – | 0.06% | 182 |
|
|
2014
Q2 | $418K | Hold |
4,141
| – | – | 0.06% | 179 |
|
|
2014
Q1 | $381K | Sell |
4,141
-11
| -0.3% | -$1.01K | 0.06% | 179 |
|
|
2013
Q4 | $376K | Sell |
4,152
-377
| -8% | -$32.6K | 0.06% | 183 |
|
|
2013
Q3 | $361K | Sell |
4,529
-627
| -12% | -$49.4K | 0.07% | 177 |
|
|
2013
Q2 | $375K | Buy |
+5,156
| New | +$386K | 0.07% | 171 |
|
Other funds holding ZBH
SCM
BTW
DLA
Trust Company of Vermont's ZBH Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 1,534 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #431 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in ZBH as recently as Q4 2025.
Trust Company of Vermont first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $611K in Q4 2019. 476 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Trust Company of Vermont held 1,534 shares of Zimmer Biomet worth $132K as of Q2 2026.
- Zimmer Biomet was a new Trust Company of Vermont position in Q2 2026.
- Zimmer Biomet made up ﹤0.01% of Trust Company of Vermont's portfolio in Q2 2026, its #431 holding.
- Trust Company of Vermont first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's Zimmer Biomet position peaked at $611K in Q4 2019.
- 476 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.